Xarelto

In the US, Xarelto (rivaroxaban systemic) is a member of the drug class factor Xa inhibitors and is used to treat Atrial Fibrillation, Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis - Recurrent Event, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism and Pulmonary Embolism - Recurrent Event.

US matches:

UK matches:

Ingredient matches for Xarelto

Rivaroxaban

Rivaroxaban is reported as an ingredient of Xarelto in the following countries:

  • Australia
  • Austria
  • Belgium
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Finland
  • France
  • Georgia
  • Germany
  • Guatemala
  • Honduras
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Mexico
  • Netherlands
  • New Zealand
  • Nicaragua
  • Norway
  • Panama
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Questions about Atrial Fibrillation? Get answers from our expert. Watch Video

Close
Hide
(web3)